Literature DB >> 26385028

Genetic mutations in African patients with atrial fibrillation: Rationale and design of the Study of Genetics of Atrial Fibrillation in an African Population (SIGNAL).

Gerald S Bloomfield1, Tecla M Temu2, Constantine O Akwanalo3, Peng-Sheng Chen4, Wilfred Emonyi3, Susan R Heckbert5, Myra M Koech6, Imran Manji3, Changyu Shen7, Matteo Vatta8, Eric J Velazquez9, Jennifer Wessel10, Sylvester Kimaiyo11, Thomas S Inui12.   

Abstract

BACKGROUND: There is an urgent need to understand genetic associations with atrial fibrillation in ethnically diverse populations. There are no such data from sub-Saharan Africa, despite the fact that atrial fibrillation is one of the fastest growing diseases. Moreover, patients with valvular heart disease are underrepresented in studies of the genetics of atrial fibrillation.
METHODS: We designed a case-control study of patients with and without a history of atrial fibrillation in Kenya. Cases with atrial fibrillation included those with and without valvular heart disease. Patients underwent clinical phenotyping and will have laboratory analysis and genetic testing of >240 candidate genes associated with cardiovascular diseases. A 12-month follow-up assessment will determine the groups' morbidity and mortality. The primary analyses will describe genetic and phenotypic associations with atrial fibrillation.
RESULTS: We recruited 298 participants: 72 (24%) with nonvalvular atrial fibrillation, 78 (26%) with valvular atrial fibrillation, and 148 (50%) controls without atrial fibrillation. The mean age of cases and controls were 53 and 48 years, respectively. Most (69%) participants were female. Controls more often had hypertension (45%) than did those with valvular atrial fibrillation (27%). Diabetes and current tobacco smoking were uncommon. A history of stroke was present in 25% of cases and in 5% of controls.
CONCLUSION: This is the first study determining genetic associations in valvular and nonvalvular atrial fibrillation in sub-Saharan Africa with a control population. The results advance knowledge about atrial fibrillation and will enhance international efforts to decrease atrial fibrillation-related morbidity.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26385028      PMCID: PMC4575772          DOI: 10.1016/j.ahj.2015.06.008

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  53 in total

1.  Atrial fibrillation in Africa: clinical characteristics, prognosis, and adherence to guidelines in Cameroon.

Authors:  Marie Ntep-Gweth; Marc Zimmermann; Alexandre Meiltz; Samuel Kingue; Pierre Ndobo; Philip Urban; Antoine Bloch
Journal:  Europace       Date:  2010-02-23       Impact factor: 5.214

2.  European ancestry as a risk factor for atrial fibrillation in African Americans.

Authors:  Gregory M Marcus; Alvaro Alonso; Carmen A Peralta; Guillaume Lettre; Eric Vittinghoff; Steven A Lubitz; Ervin R Fox; Yamini S Levitzky; Reena Mehra; Kathleen F Kerr; Rajat Deo; Nona Sotoodehnia; Meggie Akylbekova; Patrick T Ellinor; Dina N Paltoo; Elsayed Z Soliman; Emelia J Benjamin; Susan R Heckbert
Journal:  Circulation       Date:  2010-11-16       Impact factor: 29.690

Review 3.  Recommendations for the evaluation of left ventricular diastolic function by echocardiography.

Authors:  Sherif F Nagueh; Christopher P Appleton; Thierry C Gillebert; Paolo N Marino; Jae K Oh; Otto A Smiseth; Alan D Waggoner; Frank A Flachskampf; Patricia A Pellikka; Arturo Evangelista
Journal:  J Am Soc Echocardiogr       Date:  2009-02       Impact factor: 5.251

Review 4.  Chronic noncommunicable cardiovascular and pulmonary disease in sub-Saharan Africa: an academic model for countering the epidemic.

Authors:  Gerald S Bloomfield; Sylvester Kimaiyo; E Jane Carter; Cynthia Binanay; G Ralph Corey; Robert M Einterz; William M Tierney; Eric J Velazquez
Journal:  Am Heart J       Date:  2011-04-07       Impact factor: 4.749

5.  Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States.

Authors:  Karin S Coyne; Clark Paramore; Susan Grandy; Marco Mercader; Matthew Reynolds; Peter Zimetbaum
Journal:  Value Health       Date:  2006 Sep-Oct       Impact factor: 5.725

6.  Reduced prevalence of atrial fibrillation in black patients compared with white patients attending an urban hospital: an electrocardiographic study.

Authors:  Charles B Upshaw
Journal:  J Natl Med Assoc       Date:  2002-04       Impact factor: 1.798

7.  Meta-analysis identifies six new susceptibility loci for atrial fibrillation.

Authors:  Patrick T Ellinor; Kathryn L Lunetta; Christine M Albert; Nicole L Glazer; Marylyn D Ritchie; Albert V Smith; Dan E Arking; Martina Müller-Nurasyid; Bouwe P Krijthe; Steven A Lubitz; Joshua C Bis; Mina K Chung; Marcus Dörr; Kouichi Ozaki; Jason D Roberts; J Gustav Smith; Arne Pfeufer; Moritz F Sinner; Kurt Lohman; Jingzhong Ding; Nicholas L Smith; Jonathan D Smith; Michiel Rienstra; Kenneth M Rice; David R Van Wagoner; Jared W Magnani; Reza Wakili; Sebastian Clauss; Jerome I Rotter; Gerhard Steinbeck; Lenore J Launer; Robert W Davies; Matthew Borkovich; Tamara B Harris; Honghuang Lin; Uwe Völker; Henry Völzke; David J Milan; Albert Hofman; Eric Boerwinkle; Lin Y Chen; Elsayed Z Soliman; Benjamin F Voight; Guo Li; Aravinda Chakravarti; Michiaki Kubo; Usha B Tedrow; Lynda M Rose; Paul M Ridker; David Conen; Tatsuhiko Tsunoda; Tetsushi Furukawa; Nona Sotoodehnia; Siyan Xu; Naoyuki Kamatani; Daniel Levy; Yusuke Nakamura; Babar Parvez; Saagar Mahida; Karen L Furie; Jonathan Rosand; Raafia Muhammad; Bruce M Psaty; Thomas Meitinger; Siegfried Perz; H-Erich Wichmann; Jacqueline C M Witteman; W H Linda Kao; Sekar Kathiresan; Dan M Roden; Andre G Uitterlinden; Fernando Rivadeneira; Barbara McKnight; Marketa Sjögren; Anne B Newman; Yongmei Liu; Michael H Gollob; Olle Melander; Toshihiro Tanaka; Bruno H Ch Stricker; Stephan B Felix; Alvaro Alonso; Dawood Darbar; John Barnard; Daniel I Chasman; Susan R Heckbert; Emelia J Benjamin; Vilmundur Gudnason; Stefan Kääb
Journal:  Nat Genet       Date:  2012-04-29       Impact factor: 38.330

8.  Common variants in KCNN3 are associated with lone atrial fibrillation.

Authors:  Patrick T Ellinor; Kathryn L Lunetta; Nicole L Glazer; Arne Pfeufer; Alvaro Alonso; Mina K Chung; Moritz F Sinner; Paul I W de Bakker; Martina Mueller; Steven A Lubitz; Ervin Fox; Dawood Darbar; Nicholas L Smith; Jonathan D Smith; Renate B Schnabel; Elsayed Z Soliman; Kenneth M Rice; David R Van Wagoner; Britt-M Beckmann; Charlotte van Noord; Ke Wang; Georg B Ehret; Jerome I Rotter; Stanley L Hazen; Gerhard Steinbeck; Albert V Smith; Lenore J Launer; Tamara B Harris; Seiko Makino; Mari Nelis; David J Milan; Siegfried Perz; Tõnu Esko; Anna Köttgen; Susanne Moebus; Christopher Newton-Cheh; Man Li; Stefan Möhlenkamp; Thomas J Wang; W H Linda Kao; Ramachandran S Vasan; Markus M Nöthen; Calum A MacRae; Bruno H Ch Stricker; Albert Hofman; André G Uitterlinden; Daniel Levy; Eric Boerwinkle; Andres Metspalu; Eric J Topol; Aravinda Chakravarti; Vilmundur Gudnason; Bruce M Psaty; Dan M Roden; Thomas Meitinger; H-Erich Wichmann; Jacqueline C M Witteman; John Barnard; Dan E Arking; Emelia J Benjamin; Susan R Heckbert; Stefan Kääb
Journal:  Nat Genet       Date:  2010-02-21       Impact factor: 38.330

9.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.

Authors:  W B Kannel; P A Wolf; E J Benjamin; D Levy
Journal:  Am J Cardiol       Date:  1998-10-16       Impact factor: 2.778

10.  Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2014-12-18       Impact factor: 79.321

View more
  3 in total

1.  Low population prevalence of atrial fibrillation in rural Uganda: A community-based cross-sectional study.

Authors:  Rahul G Muthalaly; Bruce A Koplan; Alfred Albano; Crystal North; Jeffrey I Campbell; Bernard Kakuhikire; Dagmar Vořechovská; John D Kraemer; Alexander C Tsai; Mark J Siedner
Journal:  Int J Cardiol       Date:  2018-05-24       Impact factor: 4.164

Review 2.  Building Sustainable Capacity for Cardiovascular Care at a Public Hospital in Western Kenya.

Authors:  Cynthia A Binanay; Constantine O Akwanalo; Wilson Aruasa; Felix A Barasa; G Ralph Corey; Susie Crowe; Fabian Esamai; Robert Einterz; Michael C Foster; Adrian Gardner; John Kibosia; Sylvester Kimaiyo; Myra Koech; Belinda Korir; John E Lawrence; Stephanie Lukas; Imran Manji; Peris Maritim; Francis Ogaro; Peter Park; Sonak D Pastakia; Wilson Sugut; Rajesh Vedanthan; Reuben Yanoh; Eric J Velazquez; Gerald S Bloomfield
Journal:  J Am Coll Cardiol       Date:  2015-12-08       Impact factor: 24.094

3.  Clinical characteristics and 12-month outcomes of patients with valvular and non-valvular atrial fibrillation in Kenya.

Authors:  Tecla M Temu; Kathleen A Lane; Changyu Shen; Loise Ng'ang'a; Constantine O Akwanalo; Peng-Sheng Chen; Wilfred Emonyi; Susan R Heckbert; Myra M Koech; Imran Manji; Matteo Vatta; Eric J Velazquez; Jennifer Wessel; Sylvester Kimaiyo; Thomas S Inui; Gerald S Bloomfield
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.